Product

Company

Clareo Health | Ability to Drive of Early Stage Alzheimer Disease

NCT01566071·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

CHU de Reims

Age

70–any

Sex

ALL

Healthy volunteers

Accepted

The following subjects will be included and classified as " patients " :
Age \> 70 years
With established diagnosis of Alzheimer's disease as defined by DSM IV
With MMSE score ≥ 24 (early-stage Alzheimer's disease)
Holder of a valid driving license
With regular driving activity (drives at least once per week)
Informed consent provided.
The following subjects will be included and classified as " controls " :
Age \> 70 years,
Absence of cognitive impaired that interferes with their daily life at initial evaluation,
Holder of a valid driving license,
With regular driving activity (drives at least once per week),
Informed consent provided.

The record

StatusCompleted

PhaseNo phase

Taking part60

StartedJul 2012

UpdatedNov 26, 2025

Conditions

Where1